These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9103207)

  • 21. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metastasis in axillary lymph nodes in breast carcinoma--possibilities of mammographic diagnosis].
    Dimcić M; Stevanović O; Jakovljević B
    Srp Arh Celok Lek; 1997; 125(3-4):124-6. PubMed ID: 9221520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Axillary node removal in clinical node-negative breast carcinoma. Can its indication be individualized by "sentinel node" detection?].
    Reuhl T; Kaisers H; Markwardt J; Haensch W; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1998 May; 123(19):583-7. PubMed ID: 9618639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
    Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
    Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.
    Veronesi U; Saccozzi R; Del Vecchio M; Banfi A; Clemente C; De Lena M; Gallus G; Greco M; Luini A; Marubini E; Muscolino G; Rilke F; Salvadori B; Zecchini A; Zucali R
    N Engl J Med; 1981 Jul; 305(1):6-11. PubMed ID: 7015141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary carcinoma of the breast without axillary lymph node metastases.
    Fracchia AA; Rosen PP; Ashikari R
    Surg Gynecol Obstet; 1980 Sep; 151(3):375-8. PubMed ID: 7404307
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of axillary dissection in mammographically detected carcinoma.
    Pandelidis SM; Peters KL; Walusimbi MS; Casady RL; Laux SV; Cavanaugh SH; Bauer TL
    J Am Coll Surg; 1997 Apr; 184(4):341-5. PubMed ID: 9100677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
    J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and survival of patients with occult breast cancer with axillary lymph node metastasis: a nationwide retrospective study.
    Sohn G; Son BH; Lee SJ; Kang EY; Jung SH; Cho SH; Baek S; Lee YR; Kim HJ; Ko BS; Yu ; Lee JW; Ahn SH
    J Surg Oncol; 2014 Sep; 110(3):270-4. PubMed ID: 24863883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: an institutional analysis.
    Lee JH; Suh YJ; Shim BY; Kim SH
    Jpn J Clin Oncol; 2011 Oct; 41(10):1162-7. PubMed ID: 21903706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of the axilla in patients with screen-detected breast cancer.
    Walls J; Boggis CR; Wilson M; Asbury DL; Roberts JV; Bundred NJ; Mansel RE
    Br J Surg; 1993 Apr; 80(4):436-8. PubMed ID: 8495303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic screening and disease presentation of breast cancer patients who die of disease.
    Spencer DB; Potter JE; Chung MA; Fulton J; Hebert W; Cady B
    Breast J; 2004; 10(4):298-303. PubMed ID: 15239787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening.
    Tabar L; Chen HH; Duffy SW; Krusemo UB
    Jpn J Clin Oncol; 1999 Dec; 29(12):608-16. PubMed ID: 10721943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.